Scarica l'app Stockscreener
13.64
1.16%
-0.16
Precedente Chiudi:
$13.80
Aprire:
$13.9
Volume 24 ore:
452.15K
Relative Volume:
0.55
Capitalizzazione di mercato:
$4.83B
Reddito:
$4.79B
Utile/perdita netta:
$-317.00M
Rapporto P/E:
-14.99
EPS:
-0.91
Flusso di cassa netto:
$-59.00M
1 W Prestazione:
+1.04%
1M Prestazione:
-2.57%
6M Prestazione:
-15.28%
1 anno Prestazione:
-13.94%
Intervallo 1D:
$13.60
$13.90
Intervallo di 1 settimana:
$13.59
$15.00
Portata 52W:
$10.45
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
Nome
Bausch Lomb Corp
Settore
Industria
Telefono
908-541-5456
Indirizzo
520 APPLEWOOD CRESCENT, VAUGHAN
Confronta BLCO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
13.64 | 4.99B | 4.79B | -317.00M | -59.00M | -0.91 |
|
ISRG
Intuitive Surgical Inc
|
470.08 | 169.94B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
193.50 | 49.41B | 21.39B | 1.59B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
283.90 | 41.12B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
85.75 | 41.61B | 9.93B | 1.12B | 1.58B | 2.25 |
|
WST
West Pharmaceutical Services Inc
|
240.98 | 17.06B | 2.90B | 467.20M | 306.90M | 6.37 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-02 | Reiterato | H.C. Wainwright | Buy |
| 2025-03-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Iniziato | Raymond James | Outperform |
| 2024-05-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Iniziato | Stifel | Hold |
| 2023-10-03 | Ripresa | Evercore ISI | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Iniziato | Needham | Hold |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-12 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-06-24 | Iniziato | Evercore ISI | Outperform |
| 2022-06-06 | Iniziato | Citigroup | Buy |
| 2022-05-31 | Iniziato | Deutsche Bank | Hold |
| 2022-05-31 | Iniziato | Goldman | Neutral |
| 2022-05-31 | Iniziato | Guggenheim | Buy |
| 2022-05-31 | Iniziato | JP Morgan | Neutral |
| 2022-05-31 | Iniziato | Jefferies | Buy |
| 2022-05-31 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Iniziato | Wells Fargo | Overweight |
| 2022-05-11 | Iniziato | Cowen | Outperform |
Mostra tutto
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
Bausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
Is it the right time to buy Bausch + Lomb Corporation stockMaximize gains with proven stock analysis - Jammu Links News
Bausch + Lomb Corporation (NYSE:BLCO) Q2 2025 Earnings Call Transcript - Insider Monkey
Bausch & Lomb Raises Price Target to $16.00 Amid Positive Analyst Sentiment. - AInvest
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Raises Target Price to $16 - 富途牛牛
Bausch + Lomb:HC Wainwright Raises PT to $16, Maintains Buy Rating - AInvest
Bausch & Lomb Corp (BLCO) Q2 2025 Earnings Call Highlights: Navigating Growth Amid Challenges By GuruFocus - Investing.com Canada
Bausch + Lomb Prices Upsizes and Prices a 675-Million Euro Senior Secured Notes Offering - 富途牛牛
Bausch & Lomb Corp SEC 10-Q Report - TradingView
Bausch + Lomb Q2 Adjusted Income Lower, Revenue Increases - 富途牛牛
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Bausch + Lomb Q2 2025 beats earnings expectations - Investing.com
Bausch + Lomb Corporation - Baystreet.ca
Bausch + Lomb (BLCO) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Bausch + Lomb Announces Second-Quarter 2025 Results - BioSpace
Bausch + Lomb Lifts Outlook After Beating Revenue Expectations - Finimize
Bausch + Lomb (BLCO) Q2 Earnings and Revenues Surpass Estimates - ca.finance.yahoo.com
Bausch + Lomb: Q2 Earnings Snapshot - San Antonio Express-News
Bausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Bausch + Lomb Q2 2025 slides: Revenue growth accelerates, guidance raised By Investing.com - Investing.com South Africa
Bausch + Lomb tops Q2 expectations, raises full-year guidance By Investing.com - Investing.com Canada
Bausch + Lomb tops Q2 expectations, raises full-year guidance - Investing.com
Bausch + Lomb Q2 2025 Financial Results - TradingView
Examining the Future: Bausch & Lomb's Earnings Outlook - 富途牛牛
Bausch + Lomb Corporation Breaks Below Key Support LevelLow Volatility Stable Growth Picks Rank High - beatles.ru
Stocks In Play: Bausch + Lomb Corporation - Barchart.com
Bausch & Lomb Corp (TSX:BLCO) Q2 2025: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY® Preservative Free Redness Reliever Eye Drops - Stock Titan
Bausch + Lomb Corp expected to post earnings of 7 cents a shareEarnings Preview - TradingView
What are analysts’ price targets for Bausch + Lomb Corporation in the next 12 monthsIdentify breakout stocks before they peak - Jammu Links News
Bausch + Lomb Maintained at Outperform at RBC Ahead of Q2 Results; Price Target Kept at US$17.00 - 富途牛牛
What analysts say about Bausch + Lomb Corporation stockFree Trend-Following Techniques - Autocar Professional
Earnings Preview: BLCO to Report Financial Results Pre-market on July 30 - 富途牛牛
Bausch & Lomb amends CEO contract and performance stock unit terms By Investing.com - Investing.com South Africa
Bausch & Lomb amends CEO contract and performance stock unit terms - Investing.com Australia
Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Medical Devices & SuppliesSpecialty Stocks Q1 In Review: Bausch + Lomb (NYSE:BLCO) Vs Peers - Yahoo Finance
Is Bausch + Lomb Corporation a good long term investmentUnmatched profit growth - jammulinksnews.com
What drives Bausch + Lomb Corporation stock priceTremendous gains - jammulinksnews.com
Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie - Benzinga
Bausch + Lomb Insiders Added US$1.54m Of Stock To Their Holdings - 富途牛牛
RBC Capital Sticks to Their Buy Rating for Bausch + Lomb Corporation (BLCO) - The Globe and Mail
RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $17 - 富途牛牛
Bausch + Lomb Q2 Earnings to Benefit From FX Tailwinds, Eye Drop Sales, RBC Says - MarketScreener
RBC Capital reiterates Outperform rating on Bausch & Lomb stock ahead of Q2 earnings - Investing.com Nigeria
RBC Capital reiterates Outperform rating on Bausch & Lomb stock ahead of Q2 earnings By Investing.com - Investing.com South Africa
Stifel reiterates Hold rating on Bausch & Lomb stock, maintains $12 price target - Investing.com Nigeria
Bausch Lomb Corp Azioni (BLCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):